The Beachbody Company, Inc. reports developments in fitness programming, nutrition products, supplements, and digital wellness subscriptions under the BODi brand. The company, formerly known as Beachbody, is associated with structured home fitness programs such as P90X, INSANITY and 21 Day Fix, as well as the Shakeology protein and superfood nutrition line.
Recurring updates cover new digital workout programs, nutrition-led product extensions, retail distribution for Shakeology, P90X-branded supplements, subscription offerings, and quarterly financial results. Company news also reflects BODi’s focus on combining fitness content, nutritional products, and community-based accountability for consumers seeking home-based health and wellness routines.
BODi (NASDAQ: BODI) announced that its Shakeology nutrition shakes are now available at nearly 500 The Vitamin Shoppe stores nationwide, expanding the brand’s U.S. retail presence. The rollout covers the 0g Added Sugar line core flavors: Chocolate Vegan, Chocolate Whey, Vanilla Vegan, and a newly reformulated Vanilla Whey with zero grams of added sugar, each sold in 7-serving bags.
Originally launched in 2009 with over 1 billion servings sold, Shakeology combines protein, fiber, prebiotics, probiotics, vitamins, minerals, and more than 30 superfoods. According to BODi, a published clinical study and a survey of 1,550 customers indicate benefits for digestion, cravings, satiety, energy, and weight loss. Shakeology is also sold at over 100 Sprouts Farmers Market locations and online at BODi.com, while BODi continues broader retail expansion via its partnership with KeHE Distributors.
The Beachbody Company (NASDAQ: BODI) announced that Executive Chairman Mark Goldston and Interim Chief Financial Officer Brad Ramberg will participate in Canaccord Genuity’s 46th Annual Growth Conference on Tuesday, August 11, 2026. The company’s presentation is scheduled for 4:00 p.m. EST and will be available via live webcast through the Investors section of its website.
The Beachbody Company (NASDAQ: BODI) plans to release its second quarter 2026 financial results on Monday, August 10, 2026, after the U.S. stock market closes. The company will hold a conference call at 5:00 p.m. Eastern Time the same day, accessible via toll-free dial-in at (833) 461-5787 for U.S. and Canada, with conference ID 309733825, and via global dial-in numbers. A live webcast and a one-year replay will be available on the company’s investor relations website.
Beachbody (NASDAQ:BODI) announced that Executive Chairman Mark Goldston and Interim CFO Brad Ramberg will present virtually at the Sidoti Small Cap Conference on Thursday, June 18, 2026 at 3:15 PM ET.
A live webcast and virtual 1x1 meetings will be available via the company’s investor relations website.
BODi (NASDAQ: BODI) launched 30 Day Booty Boost, a glute-focused, 30-day fitness program led by Super Trainer Chace Collett. The program uses BODi’s Glute Activation Method, combining strength training, targeted supplementation, and simple nutrition guidance.
BODi offers a Booty Bundle: an Annual Digital Subscription for $99 after an $80 discount (about 45% savings), plus a complimentary 14-day Shakeology pack and Power Loops.
Beachbody (NASDAQ:BODI) announced that Executive Chairman Mark Goldston and Interim CFO Brad Ramberg will present at Noble Capital Markets’ Emerging Growth Virtual Equity Conference on Wednesday, June 3, 2026 at 12:00 PM ET.
The virtual fireside Q&A session will be webcast live and archived for 90 days on the company’s investor site and Channelchek.
Beachbody (NASDAQ:BODI) announced participation in two upcoming investor conferences. Executives will present at LD Micro Invitational XVI in Los Angeles on May 18, 2026, at 1:30 p.m. PT with a live webcast. They will also hold 1x1 meetings at the Craig-Hallum 23rd Annual Institutional Investor Conference on May 28, 2026.
BODi (NASDAQ:BODI) reported Q1 2026 revenue of $54.3 million, down from $72.4 million a year earlier, but exceeded the high end of guidance for revenue, net income and adjusted EBITDA.
Net income was $2.3 million versus a $5.7 million loss, and operating income reached $3.1 million versus a $3.7 million loss, marking a third consecutive profitable quarter on both metrics.
Adjusted EBITDA was $8.0 million, the tenth straight positive quarter, with gross margin at 71.8% and operating expenses reduced to $35.9 million.
Free cash flow was $(1.7) million. For Q2 2026, BODi guides revenue between $46 million and $51 million and adjusted EBITDA between $3 million and $6 million.
BODi (NASDAQ:BODI) announced a nationwide retail launch of its premium protein and superfood shake, Shakeology, at The Vitamin Shoppe locations later in 2026. The chain has over 640 stores, significantly increasing Shakeology’s brick-and-mortar presence.
Shakeology, introduced in 2009 and described as clinically studied, has generated over $4 billion in cumulative direct-to-consumer sales and more than 1 billion servings. The Vitamin Shoppe rollout follows upcoming distribution in 80+ Sprouts Farmers Market stores and supports BODi’s broader retail expansion strategy. Products will be sold in seven-serving bags at $34.99, initially in four flavors: Chocolate Whey, Vanilla Whey, Chocolate Vegan, and Vanilla Vegan.
BODi (NASDAQ: BODI) is launching Shakeology in over 80 Sprouts stores nationwide on May 18 and announced a strategic distribution partnership with KeHE, which can reach more than 30,000 retail locations. Shakeology is a 160-calorie protein and superfood shake, priced at $34.99 for a seven-serving bag.
The brand reports >$4 billion cumulative sales and 1 billion servings since 2009, offers whey and vegan formulas (17g and 16g protein), and cites a 12-week randomized clinical study in the Journal of Nutrition.